Increased circulating normal and BCR-ABL+Ve progenitor numbers in Philadelphia chromosome-positive acute myeloid leukaemia

Leukemia Research

Volumn 26, Issue 11, 2002, Pages 997-1005

  Baines, Paul ^a   Austin, Steve ^a   Fisher, Janet ^a   Owen Jones, Eleri ^a   Lee Jones, Lisa ^b   Throp, Duncan ^a   Mckinley, Mark ^a   Hoy, Terry ^b   Mills, Ken ^b   Thompson, Peter W ^b   Burnett, Alan K ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

AML; BCR ABL; Colony forming progenitors; FISH; RT PCR

Indexed keywords

BCR ABL PROTEIN; CD19 ANTIGEN; CELL SURFACE MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKOCYTE COUNT; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROMYELOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ADULT; CASE-CONTROL STUDIES; COLONY-FORMING UNITS ASSAY; DNA, NEOPLASM; ERYTHROID PROGENITOR CELLS; FLOW CYTOMETRY; FUSION PROTEINS, BCR-ABL; GENES, IMMUNOGLOBULIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LEUKOCYTE COUNT; MYELOID PROGENITOR CELLS; ONCOGENE PROTEINS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 0036842275     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00049-8     Document Type: Article

References (34)

1. Fialkow P.J., Singer J.W., Raskind W.H., Adamson J.W., Jacobsen R.J., Bernstein R.J.et al. Clonal development, stem cell differentiation and clinical remissions in acute nonlymphocytic leukemia. New Engl. Med. 317:1987;468.
2. Bernstein I.D., Singer J.W., Smith F.O., Andrews R.G., Flowers D.A., Petersens J.et al. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia. Blood. 79:1992;1811.
3. Turhan A.G., Lemoine F.M., Debert C., Bonnet M.L., Baillou C., Picard F.et al. Highly purified primitive haematopoietic stem cells are PML-RAR negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood. 85:1995;2154.
4. Raymakers R., Wittebol S., Pennings A., Linders E., Poddighe P., De Witte T. Residual normal, highly proliferative progenitors can be isolated from the CD34+/CD33- fraction of AML with a more differentiated phenotype (CD33+). Leukemia. 9:1995;450.
5. Miyamoto T., Nagafuji K., Akashi K., Harada M., Kyo T., Akashi T.et al. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood. 87:1996;4789.
6. Greaves M.F. Stem cell origins of leukemia and curability. Br. J. Cancer. 67:1993;413.
7. Moore M.A.S., Spitzer G., Williams N., Metcalf D., Buckley J. Agar culture studies in 127 cases of untreated acute leukemia: the prognostic value of reclassification of leukemia according to in vitro growth characteristics. Blood. 44:1974;1.
8. Beran M., Reizenstein P., Uden A.-M. Response to treatment in acute non-lymphatic leukaemia: prognostic value of colony-forming and colony-stimulating capacities of bone marrow and blood cells compared to other parameters. Br. J. Haematol. 44:1980;39.
9. Kitano K., Sato Y., Suda T., Miura Y. Difference of cell lineage expression of haematopoietic progenitor cells in Philadelphia-positive acute lymphoblastic leukaemia and chronic myelogenous leukaemia. Br. J. Haematol. 70:1988;21.
10. Jinnai I. In vitro growth response to G-CSF and GM-CSF by bone marrow cells of patients with acute myeloid leukemia. Leuk. Res. 14:1990;227.
11. Ailles L.E., Gerhard B., Hogge D.E. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines. Blood. 90:1997;2555.
12. Clarkson B.D., Strife A., Wisniewski D., Lambek C., Carpino N. New understanding of the pathogenesis of CML: a prototype of early neoplasia. Leukemia. 11:1997;1404.
13. Heim S, Mitelman F. Chronic myeloid leukemia. In: Cancer Cytogenetics. 2nd Ed. NY: Wiley, 1995. p. 33 (chapter 4).
14. Hermans A., Heisterkamp N., von Lindern M., van Baal S., Meijer D., van der Plas D.et al. Unique fusion of BCR and C-ABL genes in Philadelphia chromosome-positive acute lymphoblastic leukaemia. Cell. 51:1987;33.
15. Schenk T.M., Keyhani A., Bottcher S., Kliche K.-O., Goodacre A., Guo J.-Q.et al. Multilineage involvement of Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia. 12:1998;666.
16. Kurzrock R., Shtalrid M., Romero R., Kloetzer W.S., Talpaz M., Trujillo J.M.et al. A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature. 325:1987;631.
17. Clark S.S., McLaughlin J., Crist W.M., Champlin R., Witte O.N. Unique forms of the abl tyrosine kinase distinguish Ph+ CML from Ph+ ALL. Science. 235:1987;85.
18. Chan L.C., Karhi K.K., Rayter S.I., Heisterkamp N., Eridani S., Powles R.et al. A novel abl protein expressed in Philadelphia chromosome-positive acute lymphoblastic leukemia. Nature. 325:1987;635.
19. Voncken J.W., Griffiths S., Greaves M.F., Pattengale P.K., Heisterkamp N., Groffen J. Restricted oncogenicity of BCR-ABL p190 in transgenic mice. Cancer Res. 52:1992;4534.
20. Voncken J.W., Kaartinen V., Pattengale P.K., Germeraad W.T.V., Groffen J., Heisterkamp N. BCR-ABL p210 and p190 cause distinct leukemia in transgenic mice. Blood. 86:1995;4603.
21. Griffiths S.D., Healy L.E., Ford A.M., Bennet C.A., Voncken J.W., Heisterkamp N.et al. Clonal characteristics of acute lymphoblastic cells derived from BCR-ABL p190 transgenic mice. Oncogene. 7:1992;1391.
22. Castellanos A., Pintado B., Weruga E., Arevalo R., Lopez A., Orfao A.et al. A BCR-ABL (p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Blood. 90:1997;2168.
23. Li S., Ilaria R.L., Million R.P., Daley G., Van Etten R.A. The P190, P210 and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J. Exp. Med. 189:1999;1399.
24. Kurzrock R., Shtalrid M., Talpaz M., Kloetzer W.S., Gutterman J.U. Expression of C-ABL in Philadelphia-positive acute myelogenous leukemia. Blood. 70:1987;1584.
25. Kantarjian H.M., Talpaz M., Dhingra K., Estey E., Keating M.J., Ku S.et al. Significance of the p210 versus the p190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood. 78:1991;2411.
26. Selleri L., Von Lindren M., Hermans A., Meijer D., Torelli G., Grosveld G. Chronic myeloid leukemia may be associated with several BCR-ABL transcripts including the acute lymphoid leukemia-type 7 kb transcript. Blood. 75:1990;1146.
27. Kuniedo Y., Okabe M., Kurosawa M., Itaya T., Kakinuma M., Miyazaki T. Chronic myeloid leukemia presenting ALL-type bcr/abl transcript. Ann. Hematol. 69:1994;189.
28. Kirk J.A., Radich J., Edmands S., Lee A., Van Devanter D.R., Reems J.A.et al. Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia. Am. J. Hematol. 52:1996;129.
29. Saglio G., Pane F., Gottardi E., Frigeri F., Buonaiuto M.R., Guerrasio A.et al. Consistent amounts of acute leukemia-associated p190BCR-ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood. 87:1996;1075.
30. Lichty B.D., Keating A., Callum J., Yee K., Croxford R., Corpus G.et al. Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukemia. Br. J. Haematol. 103:1998;711.
31. Dhingra K., Talpaz M., Kantarjian H., Ku S., Rothberg J., Gutterman J.U.et al. Appearance of acute leukemia-associated P190 (BCR-ABL) in chronic myelogenous leukemia may correlate with disease progression. Leukemia. 5:1991;191.
32. Drouet X, Douay L, Giarratana MC, Baillou C, Gorin NC, Salmon C, et al. Human long-term bone marrow culture in serum-free medium. Exp Hematol 1988:16;abstract 367.
33. Katsura Y. Redefinition of lymphoid progenitors. Nat. Rev. Immunol. 2:2002;1.
34. Van Rhee F., Hochaus A., Lin F., Melo J.V., Goldman J.M., Cross N.C.P. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemia. Blood. 87:1996;5213.